We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our lead product, INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman’s body. This revolutionary in vivo method of vaginal incubation offers patients a more natural and intimate experience.
Recent SEC Filings
March 29, 2018 – INVO Bioscience Files 10-K for Fiscal Year 2017
November 14, 2017 – INVO Bioscience Files 10-Q for Third Quarter Fiscal Year 2017
August 10, 2017 – INVO Bioscience Files 10-Q for Second Quarter Fiscal Year 2017